Safety label guidance: Commenters want clarity, transparency, and assurances
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGenericsGuidancePharmaceuticalsRegulatory Intelligence/PolicySafety communicationUnited StatesUS Food and Drug Administration (FDA)